• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Girentuximab Antibody – Mouse Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818612

Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Girentuximab, Monoclonal Antibody
Full Product Name
Girentuximab
Product Synonym Names
cG250; WX-G250; G250
Clonality
Monoclonal
Host
Mouse
Species Reactivity
Carbonic anhydrase IX (CAIX)
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
916138-87-9
In_vitro
Girentuximab is a chimeric version of a mouse monoclonal antibody (mAb) with IgG1 kappa light chain and is capable of recognizing the CAIX antigen [1].

Other Notes

Small volumes of anti-Girentuximab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Girentuximab purchase

MBS5818612 is an antibody targeting Girentuximab. Reactive in Carbonic anhydrase IX (CAIX). Host: Mouse.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000